참고문헌
- West CM, Davidson SE, Hendry JH, Hunter RD. Prediction of cervical carcinoma response to radiotherapy. Lancet 1991;338:818
-
Hockel M, Knoop C, Schlenger K, et al. Intratumoral
$pO_{2}$ predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50 https://doi.org/10.1016/0167-8140(93)90025-4 - Begg AC, Hofland I, Van Glabekke M, Bartelink H, Horiot JC. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851. Semin Radiat Oncol 1992;2: 22-25 https://doi.org/10.1016/S1053-4296(05)80046-3
- Hockel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515
- Giaccia AJ, Brown JM, Wouters B, Denko N, Koumenis C. Cancer therapy and tumor physiology. Science 1998; 279:12-13
- Stausbol-Gron B, Overgaard J. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck. Radiother Oncol 1999;50:47-55 https://doi.org/10.1016/S0167-8140(98)00129-7
- Begg AC, Haustermans K, Hart AAM, et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol 1999;50:13-23 https://doi.org/10.1016/S0167-8140(98)00147-9
- Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res 1991; 127:308-316 https://doi.org/10.2307/3577946
- Meyn RE, Stephens LC, Ang KK, et al. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol 1993;64:583-591 https://doi.org/10.1080/09553009314551801
- Wheeler JA, Stephens LC, Tornos C, et al. ASTRO research fellowship: Apoptosis as a predictor of tumor response to radiation in stage Ib cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1487-1493 https://doi.org/10.1016/0360-3016(95)00156-S
- Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311
- Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967 https://doi.org/10.1016/0092-8674(93)90719-7
- El-Deiry Ws, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75: 817-825 https://doi.org/10.1016/0092-8674(93)90500-P
- Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-299 https://doi.org/10.1016/0092-8674(95)90412-3
- Reed JC. Double identity for proteins of the bcl-2 family. Nature 1997;387:773-776 https://doi.org/10.1038/42867
- Lee JM, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 1993;90:5742-5746 https://doi.org/10.1073/pnas.90.12.5742
- McIlwrath AJ, Vasey PA, Ross GM, Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild type p53 for radiosensitivity. Cancer Res 1994;54:3718-3722
- Kastan MB, Canman CE, Leonard CJ. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995;14:3-15 https://doi.org/10.1007/BF00690207
- Smith ML, Fornace Jr AJ. The two faces of tumor suppressor p53. Am J Pathol 1996;148:1019-1022
- Hawkins DS, Demers GW, Galloway DA. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 1996;56:892-898
- Fan S, Smith ML, Rivert II DJ, et al. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 1995;55:1649-1654
- Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 1993;53:3667-3669
- Zhang W, Kornblau SM, Kobayashi T, Gambel A, Claxton D, Deisseroth AB. High levels of constitutive WAF1/ Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin Cancer Res 1995;1:1051-1057
- Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996;381:713-716 https://doi.org/10.1038/381713a0
- Fan S, Chang JK, Smith ML, Duba D, Fornace Jr AJ, O'Connor PM. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene 1997;14:2127-2136 https://doi.org/10.1038/sj.onc.1201052
- Saito Y, Milross CG, Hittelman WN, et al. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. Int J Radiat Oncol Biol Phys 1997;38:623-631 https://doi.org/10.1016/S0360-3016(97)89488-6
- Waldman T, Zhang Y, Dillehay L, et al. Cell-cycle arrest versus cell death in cancer therapy. Nature Med 1997;3: 1034-1036 https://doi.org/10.1038/nm0997-1034
- Wouters BG, Giaccia AJ, Denko NC, Brown JM. Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis- independent mechanism. Cancer Res 1997;57:4703-4706
- Ruan S, Okcu MF, Ren JP, et al. Overexpressed WAF1/ Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis (2-chloroethyl)-1-nitrosourea and cisplatin. Cancer Res 1998;58:1538-1543
- Stephens LC, Hunter NR, Ang KK, Milas L, Meyn RE. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res 1993;135:75-80 https://doi.org/10.2307/3578399
- Milas L, Wike J, Hunter N, Volpe J, Basic I. Macrophage content of Murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Res 1987;47:1069-1075
- Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, Peters LJ. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 1995; 55:3564-3568
- Silchenmyer WJ, Nelson WG, Slebos RJ, Kastan MB. Loss of a p53 associated G1 checkpoint dose not decrease cell survival following DNA damage. Cancer Res 1993;53: 4164-4168
- Pardo FS, Su M, Borek C, et al. Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat Res 1994;140:180-185 https://doi.org/10.2307/3578901
- Russell KJ, Wiens LW, Demers GW, Dalloway DA, Plon SE, Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint deficient and G1 checkpoint competent cells. Cancer Res 1995;55:1639-1642
- O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 1993;53:4776-4780
- Maity A, Kao GD, Muschel RJ, McKenna WG. Potential molecular targets for manipulating the radiation response. Int J Radiat Oncol Biol Phys 1997;37:639-653 https://doi.org/10.1016/S0360-3016(96)00598-6
- Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-1828 https://doi.org/10.1126/science.7997877
- Jin P, Gu Y, Morgan DO. Role of inhibitory CDC2 phosphorylation in radiation induced G2 arrest in human cells. J Cell Biol 1996;134:963-970 https://doi.org/10.1083/jcb.134.4.963
-
Wu HG, Kim IH. Significance of apoptotic cell death after
$\gamma$ - irradiation. J Korean Soc Ther Radiol Oncol 2001;19:252-258 - Leoncini L, Vecchio MTD, Megha T, et al. Correlation between apoptotic and proliferative indices in malignant non- Hodgkin's lymphomas. Am J Pathol 1993;142:755-763
- Lera J, Lara PC, Perez S, Cabrera JL, Santana C. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma. Cancer 1998;83:2493-2501 https://doi.org/10.1002/(SICI)1097-0142(19981215)83:12<2493::AID-CNCR13>3.0.CO;2-C
-
Akimoto T, Seong J, Hunter NR, Buchmiller L, Mason K, Milas L. Association of increased radiocurability of murine carcinomas with low constitutive expression of
$p21^{WAF1/CIP1}$ protein. Int J Radiat Oncol Biol Phys 1999;44:413-419 https://doi.org/10.1016/S0360-3016(99)00022-X - Tamamoto T, Ohnishi K, Takahashi A, et al. Correlation between r-ray induced G2 arrest and radioresistance in two human cancer cells. Int J Radiat Oncol Biol Phys 1999;44: 905-909 https://doi.org/10.1016/S0360-3016(99)00072-3